Latest Earnings
Equities
Stock Analysis
Stock Movers
Deals
Gainers And Losers
IPOs
Technology
Artificial Intelligence
Web Stories
Benzinga Inspire
Rolando García
Benzinga Staff Writer
About
Rolando is a Benzinga Staff Writter specialized in Cannabis and Economy. He is also a scientific researcher and professor, holds a PhD in Economics, and a degree in Sociology
States Without Legal Cannabis Are Missing Out On Billions In Annual Tax Revenue, New Analysis Shows
|
Cannabis tax revenue is transforming state economies, with over $19 billion raised so far. States like California and Colorado direct cannabis tax revenue to education.
Only 3% Of Cannabis Consumed In Canada Came From Illicit Sources, National Survey Shows
|
Discover key insights from the Canadian Cannabis Survey 2024: legal access soars, smoking declines, and youth usage remains stable. Learn more about evolving cannabis trends in Canada.
New York Medical Cannabis Industry Challenges The State's System: $20M Fee Per Operator At Stake
|
The NYMCIA challenges New York's $20 million cannabis license fee in court, arguing it's unconstitutional and unfair to cannabis operators.
Benzinga's Javier Hasse Recognized As 'Cannabis Journalist Of The Year' At Emjays International Awards In Vegas
|
Benzinga's Javier Hasse wins Cannabis Journalist of the Year at Emjays International Cannabis Awards 2024 in Las Vegas, celebrating his industry contributions.
Attorney Behind Same-Sex Marriage Revives Landmark Marijuana Case: 'Congress Has Abandoned The Goal Of Eradicating Cannabis'
|
Massachusetts cannabis businesses, led by David Boies, challenge federal cannabis laws in a crucial 1st Circuit appeal.
GOP Of Texas Gears Up To Battle Cannabis Legalization
|
Texas Lt. Gov. Dan Patrick proposes Senate Bill 3 to ban THC products, intensifying the state's crackdown on cannabis reforms. They face local resistance.
Curaleaf Holdings: Is This Cannabis Company A Buy Or Hold?
|
In this article, we analyze Curaleaf using technical indicators, focusing on key levels and potential mid-term strategies. Let's dive in.
Michigan's $10 Billion Cannabis Boom: Insights On Building A Thriving Industry
|
How Michigan built a $10B cannabis market in just five years by tackling regulation, illicit trade and lab testing challenges...
Illinois New Hemp Regulations Delayed After Industry Members Voice Concerns
|
Illinois delays proposed hemp regulations following industry backlash over inspections, fees, and social equity concerns.
NASDAQ-Listed High Tide Under The Magnifying Glass: Key Insights For Cannabis Investors
|
High Tide Inc. (NASDAQ: HITI) surges to $3.55, breaking key resistance levels on high volume. In this article, we analyze High Tide using technical indicators
Nebraska's Two-Front War On Cannabis
|
Nebraska: AG Mike Hilgers leads the fight against cannabis rescheduling, representing the state in the DEA hearing with prohibitionist SAM.
EXCLUSIVE: Why Cannabis Industry Workers And Employees Should Think About 401(k) Plans
|
GreenPath 401(k) is offering retirement planning for cannabis industry workers and employers with compliant solutions.
DEA Sued For Allegedly Hiding Emails With Anti-Marijuana Group
|
Attorney Matt Zorn has sued the DEA for not disclosing records on its communications with anti-cannabis group SAM
DEA LIVE Hearings On Marijuana Rescheduling, What To Expect
|
DEA's marijuana rescheduling hearings could reshape cannabis policy, easing research and tax rules while stopping short of full legalization.
Mexico President Claudia Sheinbaum To Trump: 'Neither Threats Nor Tariffs' Will Solve Your Fentanyl Crisis
|
Mexico: Sheinbaum tells Trump the fentanyl crisis needs cooperation, not tariffs, emphasizing U.S. public health and shared responsibilities.
Cannabis Advocates Did The Draft For Trump To Make Things Right For Prohibition Victims
|
The Drug Policy Alliance (DPA) has unveiled a comprehensive draft of an executive order aimed at transforming federal cannabis policy.
Prohibitionist Group Denies Collusion Allegations Ahead Of DEA Cannabis Rescheduling Hearing
|
SAM denies collusion with the DEA amid cannabis rescheduling hearing allegations, calling the claims baseless distractions from the issue's merits.
Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunities
|
Aurora Cannabis (NASDAQ: ACB) stock finds support at $4.16 amid Fibonacci analysis and bullish divergence. Learn key levels for traders.
Minnesota's Cannabis License Lottery Faces Legal Delays Over Rejections Dispute
|
Minnesota: cannabis license lottery is delayed following lawsuits from rejected applicants, raising concerns about the state's timeline
DEA Denies Allegations Of Colluding With Anti-Marijuana Group While Involved In Cannabis Rescheduling Process
|
DEA denies allegations of improper talks with an anti-marijuana group during rescheduling, treats claims as "gossip" and requesting dismissal